Sale on Manual & Electric Hospital Beds - Starting from 25 September!
Finding non-compliant medical equipment in your inventory is a serious situation. Here is how to identify it, what the rules require, and the steps to take to protect patients and your organisation.
Non-compliant medical equipment — devices that lack valid market approval, carry incorrect certification, or fail to meet the regulatory requirements of the market where they are used — poses a serious risk. Using or placing non-compliant devices in service can harm patients, expose organisations to legal liability, invalidate insurance, and result in regulatory enforcement action. The right response is to identify the issue, act decisively, and document every step.
This guide explains how to identify non-compliant medical equipment, what to do when you find it, what organisations are required to report, and how to protect your organisation across the UK, EU, US, Gulf and South Africa.
Non-compliance in medical equipment falls into three broad categories, each requiring a different response.
Market approval failure: the device lacks valid CE, UKCA, FDA clearance, or equivalent approval for the market in which it is being used. It should not be on the market at all.
Certification or documentation failure: the device may have valid market approval, but the documentation provided has expired, is incorrect, or is fraudulent.
Device performance or safety failure: the device has valid approvals, but is performing outside its specifications or causing adverse events not anticipated in the approved risk management.
Missing or incorrect regulatory mark: a device without the CE, UKCA or FDA mark for the market where it is used, or with a mark that cannot be verified, is potentially non-compliant.
Expired or unverifiable certificates require a Declaration of Conformity, a market approval certificate, and an ISO 13485 certificate. Expired certificates or certificates from unrecognised bodies are compliance red flags.
Device not found in regulatory database: search the MHRA register, FDA 510(k) database, EUDAMED, SFDA or SAHPRA register. A legitimately approved device will appear in the relevant database.
Discrepancies between the label and documentation: if the manufacturer name, model number, or device description on the label does not match the compliance documentation, this is a serious concern requiring immediate clarification.
Receipt without documentation of a delivery of medical devices — no DoC, no certificate, no IFU — should trigger quarantine and investigation before any clinical use.
Unverifiable supplier credentials. If a supplier cannot demonstrate their own regulatory status as an authorised importer or distributor, this raises questions about the compliance of the devices they supply.
Device on an active recall: a device subject to an active recall requiring removal from service is non-compliant for continued clinical use until the required action is completed.
Post-market defect: a device in service was found to be performing outside specification — delivering incorrect dosing or giving inaccurate readings — requiring a clinical risk assessment and possibly a vigilance report.
Different types of non-compliance require different immediate responses.
|
Non-compliance type |
Immediate action |
Report required? |
|
No valid market approval |
Quarantine immediately; do not use; contact the supplier |
Consider regulator notification |
|
Expired documentation |
Quarantine; request current documentation; verify |
Not typically unless the patient is at risk |
|
Fraudulent certificates |
Quarantine; report to the regulator; contact the supplier formally |
Yes — regulator notification required |
|
Device on recall (Class I) |
Remove from service immediately; follow FSN instructions |
Confirm response with the manufacturer |
|
Performance failure in service |
Remove; investigate; submit vigilance report if criteria met |
Yes, if serious incident criteria are met |
When in doubt about whether a device is compliant or safe to use, the answer is always to quarantine until the status is confirmed. The clinical risk of using a non-compliant device is almost always greater than the disruption of removing it from service.
Need to assess a device's compliance status?
We can help you review compliance documentation and assess whether a device meets requirements for your market. Tell us the device, what you have and what concerns you — we will give you a clear picture of the compliance position.
No pressure, no obligation. → Talk to the team
A clear, documented process for handling non-compliant equipment protects both patients and your organisation.
Quarantine immediately removes the device from active service and labels it clearly as quarantined. Do not allow clinical use until the compliance issue is resolved.
Notify the clinical and management lead to promptly escalate the findings to clinical governance, quality management,t and senior management. A compliance issue requires a cross-functional response.
Document what you found and, when recorded, the device details, the compliance issue identified, the date of discovery, who found it, and the immediate action taken.
Contact the supplier formally in writing to raise the compliance concern,n requesting clarification, documentation, or resolution. Written communication creates an evidence trail.
Report to the regulator, if required; when non-compliance involves potential patient harm, or when fraudulent certification is suspected, notify the relevant regulator — MHRA, FDA, SFD, A, or SAHPRA.
Conduct a clinical risk review and assess whether any patients have been affected. If patient harm is identified or cannot be excluded, follow your clinical incident reporting process.
The decision to use a quarantined device in an emergency — where no compliant alternative is available, and the clinical risk of non-use is greater — must be made by a clinical governance lead with documented rationale. This must be a rare exception, not a routine workaround.
The best response to non-compliant equipment is to prevent it from entering the supply chain. These steps reduce the risk.
Require compliance documentation at the tender stage, including the Declaration of Conformity, CE or UKCA certificate and ISO 13485 certificate, as mandatory tender documents. Suppliers who cannot provide them should not be shortlisted.
Verify in the regulatory database before purchase; cross-check the MHRA register, FDA database, EUDAMED, SFDA, or SAHPRA before placing orders. Do not rely solely on supplier-provided documents.
Inspect labelling at goods receipt to confirm CE, UK, CA, or FDA marks are present, the model matches the order,r and documentation accompanies the delivery before accepting goods into inventory.
Use approved supplier lists, maintain a list of compliance-verified suppliers, and limit purchases to suppliers on it. Review supplier qualification regularly.
Set up field safety notifications, monitor and subscribe to MHRA Medical Device Alerts, and FDA recall notifications for device types in your inventory. Act promptly when alerts are received.
Train procurement and clinical staff to ensure everyone who orders or receives medical equipment understands what compliance documentation is required and how to raise a concern if it is missing.
Document all compliance checks; keep records of every compliance verification — database searches, document checks, inspection results. This is the evidence that your organisation acted responsibly.
Organisations with a mature compliance programme rarely encounter great non-compliance surprises. The investment in upfront verification pays back many times over by preventing a compliance failure from reaching clinical service.
These errors make non-compliance situations worse when they occur.
Continuing to use a device during an investigation, whether quarantined or suspect, while the compliance issue is under investigation, creates additional clinical risk and legal exposure. Quarantine means no clinical use.
Inadequate documentation of the issue and response leaves the organisation unable to demonstrate it acted responsibly if the matter is later reviewed by a regulator or in legal proceedings.
Handling compliance issues informally: a verbal assurance from a supplier that a documentation issue will be resolved is not sufficient. All communication about compliance concerns must be in writing.
Not reporting fraudulent certificates if a supplier has provided forged or fraudulent certificates is a criminal and regulatory matter. Notifying the regulator is the correct course of action.
Not conducting a clinical risk review when a non-compliant device has been in clinical use is a basic patient safety obligation.
Regulatory obligations for non-compliant equipment vary by market.
|
Region |
Regulator |
Non-compliance obligation |
|
United Kingdom |
Quarantine; notify MHRA for suspected fraudulent devices; serious incident report if patients harmed |
|
|
European Union |
Quarantine; notify the national competent authority; EUDAMED reporting for serious incidents |
|
|
United States |
Quarantine; notify FDA for fraudulent devices; MDR report if patients harmed |
|
|
Gulf (GCC) |
SFDA & GCC bodies |
Quarantine; notify SFDA; return to supplier; SFDA serious incident report |
|
South Africa |
Quarantine; notify SAHPRA; Medicines Act reporting obligations |
Regardless of the market, the immediate actions are the same: quarantine the device, document the issue and seek expert advice before taking further steps. Do not delay quarantine while investigating.
Buyers — source medical equipment with verified compliance documentation to reduce the risk of non-compliance.
Suppliers — list your compliant devices and provide buyers with confidence in your regulatory documentation.
Advertise — promote your products and services to a clinical audience.
Business overview — explore everything MediGear offers healthcare organisations.
This article is for general information only and does not constitute legal, regulatory, procurement or clinical advice. Non-compliance handling requirements, reporting obligations and regulatory enforcement vary by market, device type and circumstance. Always consult the relevant regulatory authority and qualified legal and regulatory professionals for advice specific to your situation and organisation. medigear.UK accepts no liability for actions taken based on this content.
If you have questions about the compliance status of medical equipment you have purchased or are considering, we can help. Tell us the device and the concern — we will review the documentation and advise on next steps.
Quarantine the device immediately by removing it from active service and clearly labelling it. Notify clinical governance and management. Document what you found and when. Contact the supplier formally in writing to request clarification or corrective action. If patients may have been harmed, conduct a clinical risk review. Report to the relevant regulator if fraudulent certification is suspected or if patients have been affected.
Non-compliant equipment lacks valid market approval, has expired or incorrect documentation, or does not meet regulatory requirements — it may be a legitimate product that has not been properly authorised. Counterfeit medical equipment is deliberately fraudulent — it may falsely claim approvals it does not have, copy a legitimate product, or carry forged certification. Both require quarantine, but counterfeiting requires immediate notification to the regulator and may require involvement of law enforcement.
Only as a last resort, with documented clinical governance approval, where the clinical risk of not using the device outweighs the risk of using a non-compliant one, and no compliant alternative is available. This must be a one-time exception with full documentation — not a recurring workaround. Even in emergencies, the supplier must be challenged and the compliance issue resolved before the device is used again in routine care.
In the UK, contact the MHRA — particularly for suspected counterfeit or fraudulent devices. In the EU, report to the national competent authority for your member state. In the US, reports to the FDA. In Saudi Arabia, report to the SFDA. In South Africa, report to SAHPRA. For serious incidents involving patient harm, report through the standard adverse event reporting route for your market,t regardless of whether the compliance issue is also being reported.
Request the Declaration of Conformity, the CE or UKCA certificate, and the ISO 13485 certificate from the supplier. Cross-check the device in the official market database— the MHRA register, the FDA 510(k) database, EUDAMED, the SFDA, or the SAHPRA register, as applicable. Check that all certificates are current, cover the specific device model, and are issued by recognised and verifiable certifying bodies. Document all checks for your procurement records.
Record the device details, including model, serial number and supplier, the nature of the compliance issue identified, the date and source of discovery, the immediate action taken, all communication with the supplier, any regulatory database checks performed, the outcome of any clinical risk review, the date and method of device quarantine or return, and confirmation of the supplier's response and resolution. Retain all records for at least 5 years, or longer, as required by your organisation's policy.